This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
fact-checked
trusted source
proofread
Encephalitis: Expert explains why early treatment is important
Encephalitis is a disease that involves the inflammation or swelling of the brain. It can happen because of infections or immune system problems, and early treatment is important. That's why Sarosh Irani, B.M.B.Ch., a neurologist and researcher at Mayo Clinic in Jacksonville, Florida, says it's essential to raise awareness.
"A number of physicians, and certainly the public, are not aware of encephalitis. Yet, it is a medical emergency, where we know that early treatment makes a major difference to our patients, both with infectious forms of the disease and the growing—and perhaps now more common—autoimmune forms of the disease," Dr. Irani says.
The two main types or divisions of encephalitis are infectious and autoimmune. In some cases, the exact cause of encephalitis remains unidentified.
Important things to know about infectious encephalitis:
- It's caused by viruses invading the brain, such as herpes and enteroviruses.
- Mosquitoes and ticks can also transmit viruses which can cause encephalitis.
- Symptoms develop quickly, over days to weeks.
Most people with infectious encephalitis start with symptoms such as headache and fever. These can progress to more severe symptoms within hours to days, such as confusion, personality changes, seizures, and loss of sensation or movement in specific body areas.
Important things to know about autoimmune encephalitis:
- The immune system mistakenly attacks the brain.
- It targets people from their first year of life to the late 80s, women and men. Some forms preferentially affect young or old; males or females.
- It can be triggered by an infection elsewhere in the body (post-infectious autoimmune encephalitis) or a tumor (paraneoplastic autoimmune encephalitis). But in about 90% of cases, the cause is not found.
- Symptoms can develop quickly, as per infectious encephalitis, or more slowly, over weeks to months, and may not include fever.
- Those symptoms of autoimmune encephalitis may include changes in personality, memory loss, problems understanding reality (psychosis), hallucinations (seeing or hearing things that aren't there), seizures, and unusual movements.
Prevention is a significant challenge, Dr. Irani says.
"We do not have consistent preventive measures for these illnesses. Only a few infectious causes may be prevented with vaccinations. There are also a few causes of infectious encephalitis that we can prevent by limiting person-to-person spread or by trying to stop, for example, vectors like mosquitoes infecting some patients. But for autoimmune causes, we don't know of ways to prevent this illness, yet this is a major question from all of our patients," he says.
Dr. Irani leads a research team studying autoimmune neurological diseases.
"One of our principal goals is to figure out how we can educate other neurologists and physicians around the world to identify patients earlier and give them early treatment," Dr. Irani says.
He says the research is about using science to create personalized treatments that make a difference for patients.
"I see ourselves as a translational research group. We see patients, care for them clinically, and obtain samples from our patients to understand their disease more closely," he says. "We then correlate clinical findings with those we obtain in our laboratory."
As for the laboratory work, he's interested in learning more about how these diseases occur.
"We want to know how the cells of the immune system that caused the illness appeared, how they perpetuate, which bodily compartments they go to, which parts of the body they reside in, and then, of course, fundamentally, how we can accurately delete them without giving the patients many side effects," Dr. Irani says.
"In the short term, I hope this research will help patients by giving physicians a better understanding of when we should treat patients, how we should recognize them, and which treatments might be most effective in which scenarios," he says.
"In the longer term, I hope we'll be able to build a platform by which we can interrogate each disease in turn and, as they all are slightly different to each other, try and ask how they cross compare to one another. And how can we offer the right patient the right treatment at the right time," Dr. Irani says.
